Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Medacta Group SA ( (CH:MOVE) ) has issued an announcement.
Medacta Group SA announced that all proposals by the Board of Directors were approved at the Annual General Meeting, including a distribution of CHF 13.7 million to shareholders and the re-election of key board members. The AGM, attended by 89.41% of the share capital, also saw the approval of various financial and remuneration reports, reinforcing Medacta’s stable governance and financial strategies.
More about Medacta Group SA
Medacta is a global leader in the healthcare industry, specializing in innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgery. Founded in 1999 in Switzerland, the company is committed to enhancing patient care and healthcare sustainability through collaboration with expert surgeons, continuous R&D investments, and cutting-edge technologies. Medacta operates in over 60 countries and supports medical education through its M.O.R.E. Institute.
Average Trading Volume: 14,286
Current Market Cap: CHF2.75B
Find detailed analytics on MOVE stock on TipRanks’ Stock Analysis page.